Detalles de la búsqueda
1.
Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study.
Ann Rheum Dis
; 82(7): 911-919, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36868796
2.
Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis.
Ann Rheum Dis
; 82(2): 189-197, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36150749
3.
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme.
Ann Rheum Dis
; 82(5): 601-610, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36787994
4.
Including uncertainty of the expected mortality rates in the prediction of loss in life expectancy.
BMC Med Res Methodol
; 23(1): 291, 2023 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38087236
5.
Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?
Ann Rheum Dis
; 81(3): 433-439, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34810197
6.
Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice.
Rheumatology (Oxford)
; 61(5): 1810-1818, 2022 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34324640
7.
Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden.
Rheumatology (Oxford)
; 61(9): 3596-3605, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34919663
8.
Assessing the impact of including variation in general population mortality on standard errors of relative survival and loss in life expectancy.
BMC Med Res Methodol
; 22(1): 130, 2022 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35501701
9.
Modelling multiple time-scales with flexible parametric survival models.
BMC Med Res Methodol
; 22(1): 290, 2022 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36352351
10.
Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden.
Ann Rheum Dis
; 80(2): 169-175, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33032998
11.
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study.
Ann Rheum Dis
; 80(8): 1086-1093, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33622688
12.
Frailty trajectories in three longitudinal studies of aging: Is the level or the rate of change more predictive of mortality?
Age Ageing
; 50(6): 2174-2182, 2021 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34120182
13.
Asthma and all-cause mortality in children and young adults: a population-based study.
Thorax
; 75(12): 1040-1046, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32963117
14.
Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study.
Breast Cancer Res Treat
; 182(3): 699-707, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32506337
15.
Adjusting Expected Mortality Rates Using Information From a Control Population: An Example Using Socioeconomic Status.
Am J Epidemiol
; 187(4): 828-836, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29020167
16.
Loss in working years after a breast cancer diagnosis.
Br J Cancer
; 118(5): 738-743, 2018 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29360816
17.
Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England.
Br J Cancer
; 117(9): 1419-1426, 2017 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28898233
18.
Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis.
RMD Open
; 9(4)2023 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37996125
19.
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden.
RMD Open
; 9(4)2023 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38151264
20.
Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases.
Rheumatol Ther
; 10(1): 201-223, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36371760